C94.0

Applicable To

• Acute myeloid leukemia M6 a) b)

• Erythroleukemia

Clinical Information

• A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

• A progressive, proliferative disease of blood cells, originating from immature erythroid cells.

• Acute erythroid leukemia characterised by the presence of at least 50% erythroid precursors and at least 20% myeloblasts in the bone marrow.

• Acute erythroid leukemia characterised by the presence of immature erythroid cells in the bone marrow at least 80% of the cellular component), without evidence of a significant myeloblastic cell population present.

• An acute myeloid leukemia characterized by a predominant immature erythroid population. There are two subtypes recognized: erythroleukemia and pure erythroid leukemia. Severe anemia is a common symptom. This leukemia usually follows an aggressive clinical course. who, 2001)

• Cancer of the blood-forming tissues in which large numbers of immature, abnormal red blood cells are found in the blood and bone marrow.

• Myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

• The progression of a myelodysplastic syndrome in which there is erythroid predominance into erythroleukemia m6a or erythroleukemia, erythroid/myeloid).

Details

• C94.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.

• The 2023 edition of ICD-10-CM C94.0 became effective on October 1, 2022.

• This is the American ICD-10-CM version of C94.0 – other international versions of ICD-10 C94.0 may differ.